Drugs / FG2216
last change Jul 2007 re-read 3 minutes ago

FG2216

Developed for
anemia
Investigated by
Kyntra Bio

Trials 1

2006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT00456053 Dec 2005 → Jul 2007 anemia Kyntra Bio Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as FG2216 ClinicalTrials.gov intervention name — accepted as the source's own label NCT00456053 ↗